1) The production of innovative formulations, novel delivery vehicles, and/or device approaches to extend a once daily injection to a longer dosing regime.
2) The capability to enable oral delivery of peptide and nucleic acid therapeutics, with a vision to take the injection to a pill.
You are about to update of their linked CA work items. This process cannot be undone. Are you sure?